Table 2.
Details of the blood culture results reported for the five misidentified melioidosis cases from Chiang Rai, Thailand
| Patient | Collection time (day 0=admission) | Report time (hours after collection) | Results | Antibiotic susceptibility (S = Sensitive, I = Intermediate sensitivity, R = Resistant) |
|---|---|---|---|---|
| 1 | Day 0 | 37 h | Acinetobacter lwoffii | S—ceftazidime, imipenem, cefoperazone/sulbactam R—amikacin, gentamicin, co-trimoxazole |
| 2 | Day 0 | 28 h | Mixed growth: A. lwoffii, Staphylococcus epidermidis | S—ceftazidime, imipenem, piperacillin-tazobactam, cefoperazone/sulbactam, ciprofloxacin, ertapenem, meropenem, cefotaxime, co-trimoxazole R—amikacin, gentamicin NB—susceptibility results for Acinetobacter lwoffii only |
| Day 2 | 99 h | Burkholderia pseudomallei | S—ceftazidime, imipenem, cefoperazone/sulbactam R—amikacin, gentamicin, co-trimoxazole | |
| 3 | Day 0 | 40 h | Acinetobacter baumannii | S—ceftazidime, doripenem, imipenem, piperacillin-tazobactam, cefoperazone/sulbactam, ertapenem, meropenem, cefotaxime R—amikacin, gentamicin, co-trimoxazole |
| 4 | Day 0 | 22 h | A. baumannii | S—ceftazidime, doripenem, imipenem, piperacillin-tazobactam, cefoperazone/sulbactam, ertapenem, meropenem, cefotaxime R—amikacin, gentamicin, co-trimoxazole |
| 5 | Day 0 | 25 h | A. lwoffii | S—ceftazidime, doripenem, imipenem, piperacillin-tazobactam, cefoperazone/sulbactam, ertapenem, meropenemI—cefotaxime R—amikacin, gentamicin, co-trimoxazole |
NB: antibiotic susceptibility results were generally reported 16–24 h after the blood culture flagged positive.